Trustmark Corporation logo TRMK - Trustmark Corporation

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 0
HOLD 7
SELL 2
STRONG
SELL
0
| PRICE TARGET: $45.50 DETAILS
HIGH: $45.50
LOW: $45.50
MEDIAN: $45.50
CONSENSUS: $45.50
UPSIDE: 2.48%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 29.1% below fair value
Current Price $44.40
Bear Case $39.65 10.7% downside ($39.65 - $44.40) / $44.40 = -10.7% ROTCE 9.4% → 1.39x TBV
Fair Value $62.64 41.1% upside ($62.64 - $44.40) / $44.40 = 41.1% ROTCE 12.5% → 2.20x TBV
Bull Case $76.45 72.2% upside ($76.45 - $44.40) / $44.40 = 72.2% ROTCE 14.4% → 2.68x TBV

Adjust Assumptions

12.5%
7.9%

Key Value Driver

ROTCE (12.5%) vs. cost of equity (7.9%)

Implied Market Multiple 1.46x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $45.50 from 9 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $62.64 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $14.99 (78% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $45.50 (from 9 analysts). Our estimate is 47% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly